| Cardiogenic shock complicating acute coronary syndromes. | |
| | |
MedLine Citation:
|
PMID: 11085707 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cardiogenic shock remains the major cause of death among patients with all types of acute coronary syndromes. Thus, there is a growing interest in the identification of patients who are at risk for developing cardiogenic shock, in the exploration of different therapeutic approaches to preventing its development, and in the improvement of outcome when it occurs. This article reviews the aetiology and pathophysiology of cardiogenic shock, its epidemiology, its treatment (including pharmaceutical agents, counterpulsation, and revascularisation), and its outcome. Algorithms are presented that predict its occurrence in both ST-segment-elevation myocardial infarction and unstable angina or non-ST-elevation myocardial infarction, and that predict its mortality in patients with ST-segment-elevation acute myocardial infarction. Such new areas as metabolic therapy and glycoprotein IIb/IIIa inhibitors are discussed, as are the economic implications of shock. |
| | |
Authors:
|
D Hasdai; E J Topol; R M Califf; P B Berger; D R Holmes |
Related Documents
:
|
16678027 - Improved survival after acute myocardial infarction complicated by cardiogenic shock wi... 8709357 - The use of ungating with the medstone lithotriptor. 12601497 - Acute myocardial infarction after bone marrow transplantation: an unsuspected late comp... 15502507 - Management strategies for cardiogenic shock. 20113477 - Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarc... 8294357 - Complications in 1000 consecutive treadmill tests. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Lancet Volume: 356 ISSN: 0140-6736 ISO Abbreviation: Lancet Publication Date: 2000 Aug |
Date Detail:
|
Created Date: 2000-11-30 Completed Date: 2000-11-30 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 2985213R Medline TA: Lancet Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 749-56 Citation Subset: AIM; IM |
Affiliation:
|
Rabin Medical Center, Petah Tikva, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adult Aged Aged, 80 and over Algorithms Coronary Disease / complications Electrocardiography Fibrinolytic Agents / therapeutic use Humans Middle Aged Predictive Value of Tests Randomized Controlled Trials as Topic Risk Factors Shock, Cardiogenic* / complications, etiology, physiopathology, therapy |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents |
| Comments/Corrections | |
Comment In:
|
Lancet. 2000 Nov 11;356(9242):1687-8
[PMID:
11089851
]
Lancet. 2000 Nov 11;356(9242):1687 [PMID: 11089850 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impaired chemosensitivity and perception of dyspnoea in Parkinson's disease.
Next Document: US public health and the 21st century: diabetes mellitus.